Colchicine News and Research

RSS
Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Moscow scientists discover and explain the activity mechanism of new anti-cancer molecule

Moscow scientists discover and explain the activity mechanism of new anti-cancer molecule

Genome-wide CRISPR screens reveal resistance and sensitization mechanisms of drugs used in COVID-19

Genome-wide CRISPR screens reveal resistance and sensitization mechanisms of drugs used in COVID-19

Gout medication reduces major cardiovascular events in heart patients

Gout medication reduces major cardiovascular events in heart patients

Repurposing immunosuppressants to manage COVID-19

Repurposing immunosuppressants to manage COVID-19

ACR releases new guideline for management of gout

ACR releases new guideline for management of gout

Study reveals molecular pathogenesis of muscular dystrophy-associated cardiomyopathy

Study reveals molecular pathogenesis of muscular dystrophy-associated cardiomyopathy

Gout treatment could potentially reduce complications accompanying metabolic syndrome

Gout treatment could potentially reduce complications accompanying metabolic syndrome

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

Novel cellular pathway may clarify how arterial inflammation develops into atherosclerosis

Novel cellular pathway may clarify how arterial inflammation develops into atherosclerosis

Scientists define working mechanism of promising anti-cancer molecules

Scientists define working mechanism of promising anti-cancer molecules

Article reviews impact of adding pyridine based antitumor compounds at colchicine site

Article reviews impact of adding pyridine based antitumor compounds at colchicine site

ESC publishes new guidelines on pericardial diseases

ESC publishes new guidelines on pericardial diseases

Helsinn's Akynzeo for CINV prevention receives EC approval

Helsinn's Akynzeo for CINV prevention receives EC approval

Fewer patients take effective gout drug after steep price increase

Fewer patients take effective gout drug after steep price increase

AbbVie gets European Commission's approval to market VIEKIRAX + EXVIERA for HCV treatment

AbbVie gets European Commission's approval to market VIEKIRAX + EXVIERA for HCV treatment

Hikma prepares to launch colchicine 0.6mg capsules in the US market

Hikma prepares to launch colchicine 0.6mg capsules in the US market

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Crealta publishes review of post-hoc safety analysis completed for Krystexxa

Crealta publishes review of post-hoc safety analysis completed for Krystexxa

Plant-based medication after cardiac surgery shows mixed results in reducing complications

Plant-based medication after cardiac surgery shows mixed results in reducing complications